Oppenheimer & Co. Inc. Buys 64,154 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Oppenheimer & Co. Inc. grew its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 167.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 102,535 shares of the construction company’s stock after acquiring an additional 64,154 shares during the period. Oppenheimer & Co. Inc.’s holdings in Aspen Aerogels were worth $2,839,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. BNP Paribas Financial Markets raised its holdings in Aspen Aerogels by 85.2% in the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock worth $452,000 after purchasing an additional 11,823 shares in the last quarter. Swiss National Bank boosted its stake in Aspen Aerogels by 16.2% during the 1st quarter. Swiss National Bank now owns 120,500 shares of the construction company’s stock valued at $2,121,000 after purchasing an additional 16,800 shares during the last quarter. Vanguard Group Inc. lifted its stake in Aspen Aerogels by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after acquiring an additional 175,906 shares during the period. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Aspen Aerogels during the first quarter valued at approximately $851,000. Finally, Hood River Capital Management LLC boosted its stake in shares of Aspen Aerogels by 12.2% in the 1st quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock worth $58,088,000 after buying an additional 357,895 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Stock Down 5.4 %

Shares of ASPN stock opened at $14.28 on Friday. The stock has a market cap of $1.17 billion, a P/E ratio of 1,429.43 and a beta of 2.21. Aspen Aerogels, Inc. has a twelve month low of $9.89 and a twelve month high of $33.15. The stock has a 50 day moving average of $22.04 and a 200 day moving average of $24.59. The company has a current ratio of 2.93, a quick ratio of 2.82 and a debt-to-equity ratio of 0.27.

Insider Buying and Selling

In related news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. This trade represents a 60.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

ASPN has been the topic of several analyst reports. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research report on Wednesday. Piper Sandler cut their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. HC Wainwright reissued a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Roth Mkm dropped their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Finally, Barclays reduced their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and an average price target of $28.70.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.